Abstract:Background: Osteosarcoma (OS) is the leading cancer-associated mortality in childhood and adolescence. Increasing evidence has demonstrated the key function of microRNAs (miRNAs) in OS development and chemoresistance. Among them, miRNA-605-3p acted as an important tumor suppressor and was frequently down-regulated in multiple cancers. However, the function of miR-650-3p in OS has not been reported. Objective: The aim of this work is to explore the novel role of miR-605-3p in osteosarcoma and its possible involvement in OS chemotherapy resistance. Method: The expression levels of miR-605-3p in OS tissues and cells were assessed by reverse transcription quantitative PCR (RT-qPCR). The relevance of miR-605-3p with the prognosis of OS patients was determined by the Kaplan-Meier analysis. Additionally, the influence of miR-605-3p on OS cell growth was analyzed using the cell counting kit-8, colony formation assay, and flow cytometry. The mRNA and protein expression of RAF1 were detected by RT-qPCR and western blot. The binding of miR-605-3p with the 3'-UTR of RAF1 was confirmed by dual-luciferase reporter assay. Results: Our results showed that miR-605-3p was markedly decreased in OS tissues and cells. A lower level of miR-605-3p was strongly correlated with lymph node metastasis and poor 5-year overall survival rate of OS patients. In vitro assay found that miR-605-3p suppressed OS cell proliferation and promoted cell apoptosis. Mechanistically, the proto-oncogene RAF1 was seen as a target of miR-605-3p and strongly suppressed by miR-605-3p in OS cells. Restoration of RAF1 markedly eliminated the inhibitory effect of miR-605-3p on OS progression, suggesting RAF1 as a key mediator of miR-605-3p. Consistent with the decreased level of RAF1, miR-605-3p suppressed the activation of both MEK and ERK in OS cells, which are the targets of RAF1. Moreover, lower levels of miR-605-3p were found in chemoresistant OS patients, and downregulated miR-605-3p increased the resistance of OS cells to therapeutic agents. Conclusion: Our data revealed that miR-605-3p serves as a tumor suppressor gene by regulating RAF1 and increasing the chemosensitivity of OS cells, which provided the novel working mechanism of miR-605-3p in OS. Engineering stable nanovesicles that could efficiently deliver miR-605-3p with therapeutic activity into tumors could be a promising therapeutic approach for the treatment of OS.

MicroRNA-618 Directly Targets Metadherin Mrna to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Ott_a_219440 9795..9807

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

MicroRNA-1236-3p Inhibits Human Osteosarcoma Growth

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-876-5p Inhibits Cell Proliferation, Migration and Invasion by Targeting C-Met in Osteosarcoma.

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

Microrna-613 Suppresses Proliferation, Migration and Invasion of Osteosarcoma by Targeting C-Met

Mir-624-5p Promoted Tumorigenesis and Metastasis by Suppressing Hippo Signaling Through Targeting PTPRB in Osteosarcoma Cells.

MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1

MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis

MicroRNA-192 Inhibits the Proliferation, Migration and Invasion of Osteosarcoma Cells and Promotes Apoptosis by Targeting Matrix Metalloproteinase-11.

HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2

Mir-92A Promotes Tumor Growth of Osteosarcoma by Targeting PTEN/AKT Signaling Pathway.

Microrna-499a-5p Inhibits Osteosarcoma Cell Proliferation And Differentiation By Targeting Protein Phosphatase 1d Through Protein Kinase B/Glycogen Synthase Kinase 3 Beta Signaling

MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma.

MicroRNA-187 Suppresses the Proliferation Migration and Invasion of Human Osteosarcoma Cells by Targeting MAPK7.

Retracted: Inhibition of Microrna-940 Suppresses the Migration and Invasion of Human Osteosarcoma Cells Through the Secreted Frizzled-Related Protein 1-Mediated Wnt/β-catenin Signaling Pathway.

MicroRNA-205 Acts As a Tumor Suppressor in Osteosarcoma Via Targeting RUNX2